Advances in mRNA nanomedicines for malignant brain tumor therapy
Nowadays, malignant brain tumors are still mostly lethal diseases with poor prognosis and a clinical median survival rate of fewer than 2 years after therapeutic intervention. It is difficult to achieve complete remission of brain tumors due to blood-brain barrier (BBB) and a lack of efficient drug...
| 發表在: | Smart Materials in Medicine |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
KeAi Communications Co., Ltd.
2023-01-01
|
| 主題: | |
| 在線閱讀: | http://www.sciencedirect.com/science/article/pii/S2590183422000527 |